These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15157857)

  • 1. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure.
    Yu T; Huang X; Hu K; Bai J; Wang Z
    Ultrason Sonochem; 2004 Jul; 11(5):287-91. PubMed ID: 15157857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers.
    He H; Yu T; Zhang Y
    Ultraschall Med; 2012 Jun; 33(3):275-82. PubMed ID: 21165815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro.
    Yu T; Bai J; Hu K; Wang Z
    Ultrason Sonochem; 2004 Apr; 11(2):89-94. PubMed ID: 15030785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of models in "target" theory to evaluate the survival curves of human ovarian carcinoma cell line exposure to adriamycin combined with ultrasound.
    Yu T; Xiong Z; Chen S; Tu G
    Ultrason Sonochem; 2005 Apr; 12(5):345-8. PubMed ID: 15590307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound increases DNA damage attributable to cisplatin in cisplatin-resistant human ovarian cancer cells.
    Yu T; Yang Y; Liu S; Yu H
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):355-9. PubMed ID: 19204912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of adriamycin resistance in ovarian carcinoma cell line by combination of verapamil and low-level ultrasound.
    Yu T; Hu K; Bai J; Wang Z
    Ultrason Sonochem; 2003 Jan; 10(1):37-40. PubMed ID: 12457949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonic therapy for gynecologic tumors.
    Yu T; Zhou S; Zhang J
    J Minim Invasive Gynecol; 2008; 15(6):667-72. PubMed ID: 18774758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities].
    Zhang L
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure alterations in adriamycin-resistant and cisplatin-resistant human ovarian cancer cell lines exposed to nonlethal ultrasound.
    Yu T; Huang X; Jiang S; Hu K; Kong B; Wang Z
    Int J Gynecol Cancer; 2005; 15(3):462-7. PubMed ID: 15882170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells.
    Bernard V; Skorpíková J; Mornstein V; Slaninová I
    Ultrasonics; 2010 Mar; 50(3):357-62. PubMed ID: 19740505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound in ovarian cancer xenografts.
    Wu R; Hu B; Jiang LX; Hung Y; Kuang SL; Zhang B
    Adv Ther; 2008 Aug; 25(8):810-9. PubMed ID: 18704281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.
    Qian HN; Li WJ
    Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermosensitivity and thermotolerance in the adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1996; 16(5A):2569-73. PubMed ID: 8917353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of thermochemotherapy on human ovarian cancer xenograft transplanted to nude mice--using antineoplastic agents of different drug sensitivity].
    Sagawa T; Yamashita K; Yorozu Y; Kawamura M; Shimizu T
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1117-24. PubMed ID: 3430006
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.